Creative Planning’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-24,691
| Closed | -$84K | – | 2002 |
|
|
2018
Q3 | $84K | Hold |
24,691
| – | – | ﹤0.01% | 1792 |
|
|
2018
Q2 | $93K | Sell |
24,691
-4,348
| -15% | -$16.4K | ﹤0.01% | 1764 |
|
|
2018
Q1 | $119K | Buy |
29,039
+1,500
| +5% | +$6.15K | ﹤0.01% | 1700 |
|
|
2017
Q4 | $128K | Sell |
27,539
-9,000
| -25% | -$41.8K | ﹤0.01% | 1686 |
|
|
2017
Q3 | $259K | Sell |
36,539
-200
| -0.5% | -$1.42K | ﹤0.01% | 1419 |
|
|
2017
Q2 | $266K | Hold |
36,739
| – | – | ﹤0.01% | 1348 |
|
|
2017
Q1 | $226K | Hold |
36,739
| – | – | ﹤0.01% | 1404 |
|
|
2016
Q4 | $215K | Sell |
36,739
-50
| -0.1% | -$293 | ﹤0.01% | 1373 |
|
|
2016
Q3 | $195K | Buy |
36,789
+6,000
| +19% | +$31.8K | ﹤0.01% | 1404 |
|
|
2016
Q2 | $204K | Sell |
30,789
-5,550
| -15% | -$36.8K | ﹤0.01% | 1242 |
|
|
2016
Q1 | $170K | Buy |
36,339
+5,690
| +19% | +$26.6K | ﹤0.01% | 1296 |
|
|
2015
Q4 | $155K | Buy |
30,649
+18,618
| +155% | +$94.2K | ﹤0.01% | 1357 |
|
|
2015
Q3 | $42K | Sell |
12,031
-940
| -7% | -$3.28K | ﹤0.01% | 2154 |
|
|
2015
Q2 | $129K | Buy |
12,971
+500
| +4% | +$4.97K | ﹤0.01% | 939 |
|
|
2015
Q1 | $159K | Sell |
12,471
-2,100
| -14% | -$26.8K | ﹤0.01% | 1306 |
|
|
2014
Q4 | $206K | Buy |
14,571
+3,200
| +28% | +$45.2K | ﹤0.01% | 1120 |
|
|
2014
Q3 | $156K | Sell |
11,371
-5,934
| -34% | -$81.4K | ﹤0.01% | 1203 |
|
|
2014
Q2 | $266K | Buy |
17,305
+7,671
| +80% | +$118K | ﹤0.01% | 893 |
|
|
2014
Q1 | $164K | Sell |
9,634
-3,000
| -24% | -$51.1K | ﹤0.01% | 1101 |
|
|
2013
Q4 | $164K | Sell |
12,634
-1,700
| -12% | -$22.1K | ﹤0.01% | 951 |
|
|
2013
Q3 | $145K | Sell |
14,334
-100
| -0.7% | -$1.01K | ﹤0.01% | 908 |
|
|
2013
Q2 | $108K | Buy |
+14,434
| New | +$108K | ﹤0.01% | 942 |
|